Paysign (NASDAQ:PAYS) Stock Price Expected to Rise, Ladenburg Thalmann & Co. Inc. Analyst Says

Paysign (NASDAQ:PAYS) had its target price upped by stock analysts at Ladenburg Thalmann & Co. Inc. from $14.00 to $15.25 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Ladenburg Thalmann & Co. Inc.‘s price target indicates a potential upside of 60.44% from the stock’s current price.

A number of other research firms have also recently issued reports on PAYS. Barrington Research set a $15.00 target price on Paysign in a research report on Tuesday, August 11th. Wall Street Zen downgraded Paysign from a “strong-buy” rating to a “buy” rating in a research note on Sunday, August 16th. Lake Street Capital increased their target price on shares of Paysign from $13.00 to $15.00 and gave the stock a “buy” rating in a report on Tuesday, September 15th. Maxim Group downgraded shares of Paysign from a “buy” rating to a “hold” rating in a research note on Wednesday. Finally, Weiss Ratings upgraded shares of Paysign from a “buy (b-)” rating to a “buy (b)” rating in a research note on Thursday, October 8th. Four investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, Paysign has an average rating of “Moderate Buy” and a consensus price target of $14.81.

Paysign Stock Down 6.3%

Shares of PAYS stock traded down $0.64 during trading hours on Wednesday, reaching $9.51. The company’s stock had a trading volume of 1,610,150 shares, compared to its average volume of 757,623. The firm’s 50 day simple moving average is $13.82 and its 200-day simple moving average is $8.63. The company has a market capitalization of $536.67 million, a price-to-earnings ratio of 28.80 and a beta of 0.92. Paysign has a fifty-two week low of $3.08 and a fifty-two week high of $16.15.

Paysign (NASDAQ:PAYS) last posted its quarterly earnings results on Monday, November 9th. The company reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.02. Paysign had a return on equity of 37.20% and a net margin of 18.48%. The company had revenue of $30.80 million during the quarter, compared to analysts’ expectations of $29.02 million. Sell-side analysts predict that Paysign will post 0.58 earnings per share for the current year.

Insider Activity

In other news, insider Michael Ngo sold 79,925 shares of the stock in a transaction on Wednesday, September 9th. The stock was sold at an average price of $12.74, for a total value of $1,018,244.50. Following the completion of the transaction, the insider directly owned 2,350,000 shares in the company, valued at approximately $29,939,000. This represents a 3.29% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Mark Newcomer sold 50,000 shares of the firm’s stock in a transaction on Friday, October 9th. The shares were sold at an average price of $15.34, for a total value of $767,000.00. Following the sale, the chief executive officer directly owned 9,113,002 shares in the company, valued at approximately $139,793,450.68. This trade represents a 0.55% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 259,904 shares of company stock worth $3,402,424. Insiders own 24.50% of the company’s stock.

Institutional Trading of Paysign

A number of hedge funds have recently made changes to their positions in PAYS. BlackRock Inc. bought a new position in Paysign in the 2nd quarter valued at approximately $25,219,000. Punch & Associates Investment Management Inc. bought a new stake in Paysign during the 2nd quarter worth approximately $16,983,000. Renaissance Technologies LLC grew its holdings in Paysign by 17.4% during the 1st quarter. Renaissance Technologies LLC now owns 1,531,072 shares of the company’s stock worth $9,033,000 after acquiring an additional 227,300 shares during the last quarter. AWM Investment Company Inc. bought a new stake in Paysign during the 2nd quarter worth approximately $6,560,000. Finally, Dimensional Fund Advisors LP increased its position in Paysign by 16.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 575,619 shares of the company’s stock valued at $3,396,000 after acquiring an additional 82,736 shares during the period. 25.89% of the stock is owned by institutional investors and hedge funds.

Key Stories Impacting Paysign

Here are a few of the latest stories about PAYS:

• Positive Sentiment: Q3 revenue rose 42.6% year over year to a record $30.8 million, beating estimates, while EPS of $0.11 topped the $0.09 consensus. The operating margin more than tripled to 23.8%; pharma revenue grew 109.8%. Paysign Q3 2026 results
• Positive Sentiment: DA Davidson lowered its price target to $14 from $15 but maintained a Buy rating, indicating the firm still sees upside. DA Davidson recommendations
• Negative Sentiment: A MarketWatch report cited a customer’s pullback as a risk to future revenue, adding concern about growth beyond the strong quarter. Customer pullback weighs on future revenue

Paysign Company Profile

Paysign, Inc. provides prepaid card programs, payment processing and related financial technology services. Its platform supports organizations that need to distribute funds and manage payments, including businesses in the healthcare sector. The company serves plasma collection centers with donor compensation and payment solutions, and works with pharmaceutical companies on patient assistance and affordability programs. Its services also support payments for clinical trials and other disbursement needs.